【私募调研记录】睿璞投资调研三维化学

Group 1 - The core viewpoint of the article highlights the recent research conducted by the well-known private equity firm Ruipu Investment on a listed company, Sanwei Chemical, which has shown significant growth in revenue and net profit in the first half of 2025 [1] - Sanwei Chemical achieved an operating revenue of 1,248.81 million yuan, representing a year-on-year increase of 21.81%, and a net profit attributable to shareholders of 120.36 million yuan, up 42.54% year-on-year [1] - The company has a total of signed but uncompleted orders amounting to 1,629.46 million yuan in its engineering business, indicating a strong backlog and future revenue potential [1] Group 2 - Sanwei Chemical employs a flexible production model that adapts to market demand, focusing on optimizing its products and enhancing its technological capabilities in sulfur recovery and comprehensive utilization of C4 resources [1] - The company plans to distribute a cash dividend of 1.00 yuan per 10 shares, totaling 64.89 million yuan, reflecting its cash-rich position and commitment to returning value to shareholders [1] - Future strategies include optimizing existing operations and actively expanding into downstream fine chemicals, while also considering opportunities for external growth [1]